Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Weit, Jeffrey I
  • Cao, Charlie
  • Eriksson, Bengt
  • Fisher, William D
  • Kupfer, Stuart
  • Raskob, Gary E
  • Spaeder, Jeffrey
  • Turpie, Alexander Graham Gri

publication date

  • November 20, 2009

published in